Switchpoint Bio
Switchpoint Bio is an artificial intelligence company in Helsinki, Finland, founded in 2025. It has raised $5.3M across 1 round, most recently a $5.3M Pre-Seed in November 2026.
- Headquarters
- Helsinki
- Employees
- 1–10
- Founded
- 2025
- Website
- switchpointbio.com
- Total Funding
- $5.3M
- Last Round
- $5.3M Pre-SeedNov 2026
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round for this company. The full record is or through the API.
About
Switchpoint Bio combines epigenomics and AI to turn cellular biology into evidence for drug development and clinical research. Its platform reads blood-based epigenomic signatures to reveal disease states and their underlying cellular mechanisms. It supports biomarker discovery, identification of biologically defined patient groups for clinical trials, and tracking cellular changes associated with treatment response, resistance, and mechanism of action.
Summary
It lists 1–10 employees. It has raised $5.3M in total across 1 round, most recently a $5.3M Pre-Seed round in Nov 2026.
Funding History
Nov 2026
Similar Companies

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic develops reliable, interpretable, and steerable AI systems, translating frontier safety...
xAI builds AI systems, including Grok, with frontier reasoning, voice, and generative media capab...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/switchpoint-bio"><img src="https://indexed.vc/api/badge/company/switchpoint-bio" alt="Switchpoint Bio on Indexed.vc" width="260" height="76" /></a>
